Back

Characterization of circulating miRNA21 in young and elderly patients with symptomatic hypertrophic cardiomyopathy

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Cardiomyopathy Hypertrophic cardiomyopathy HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Miss Tinatin Bezhanishvili

Saint Petersburg First Pavlov State Medical University, Saint Petersburg (Russian Federation)

36 More presentations in this session

Presentation thumbnail
Pregnancy in women with hypertrophic cardiomyopathy: data from the European Society of Cardiology initiated Registry of Pregnancy and Cardiac disease (ROPAC)
Doctor S. Goland (Rehovot, IL)
Abstract Slides
Presentation thumbnail
Serum NT-probrain natriuretic peptide and high-sensitivity cardiac troponin I levels in carriers of myosin-binding protein C founder mutation
Assistant Professor G. Gunnarsson (Akureyri, IS)
Abstract Slides
Presentation thumbnail
Echocardiographically estimated pulmonary artery systolic pressure predicts progressive heart failure and systemic embolic events in patients with hypertrophic cardiomyopathy
Doctor K. Kanbayashi (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Can plasma proteomic profiling differentiate patients with hypertrophic cardiomyopathy from other cardiovascular patients?
Professor R. Pudil (Prague, CZ)
Abstract Slides
Presentation thumbnail
Heart fatty acid binding protein and glycogen phosphorylase bb are associated with the morphologic and functional parameters in patients with non-obstructive hypertrophic cardiomyopathy
Professor R. Pudil (Prague, CZ)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Cardiomyopathy

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources